Status:
ACTIVE_NOT_RECRUITING
PRISM for Depression and Anxiety in Young Adults With Cancer
Lead Sponsor:
Dana-Farber Cancer Institute
Conditions:
Cancer Diagnosis
Non-Metastatic Neoplasm
Eligibility:
All Genders
18-39 years
Phase:
NA
Brief Summary
This research study is being done to test the feasibility of an existing supportive program (PRISM) to address psychological symptoms (i.e., depressive and anxiety symptoms) that young adult participa...
Detailed Description
This research study is being done to test the initial feasibility and acceptability of a six-session, skills-based resilience coaching intervention, Promoting Resilience in Stress Management (PRISM; R...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Participants:
- 18-39 years of age
- Speak and comprehend English sufficiently to be able to complete study procedures and participate in the program in English\*
- Have been diagnosed with cancer or desmoid tumor at least 6 or more weeks ago
- Currently receiving treatment or has completed treatment for cancer or desmoid tumor no more than 6 months ago
- Score 10-24 (with question #9 not endorsed, or 0) on the PHQ-9 (Kroenke et al., 1999) or/and score 10-21 on the GAD-7 (Spitzer et al., 2006) during the initial screening assessment.
- Participant Exclusion Criteria:
- Adults unable to consent, individuals who are not yet adults (age \<18), pregnant women, and prisoners.
- Individuals who score less than 10 on both PHQ-9 and GAD-7.
- Individuals who are diagnosed with cancer less than 6 weeks at the time of screening (we will be able to approach them again after 6 weeks since diagnosis has passed), or those who completed treatment more than 6 months ago will also be ineligible for this study; they will be offered resources for support, if desired.
- 5\) Individuals who report any suicidality (ideation, plan, and/or intent) on PHQ-9 screen (i.e., endorse anything more than 0 for question #9) at the time of the eligibility screening will also be excluded from the current study, and the appropriate safety measures and/or referral to a mental health provider will be made (see section 14.1 for more details on the procedure).
- Inclusion Criteria for Support Person:
- ≥ 18 years of age
- A friend or family member invited by the study participant to join the 6th PRISM session
Exclusion
Key Trial Info
Start Date :
September 6 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06502483
Start Date
September 6 2024
End Date
February 1 2026
Last Update
December 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana-Farber Cancer Institute
Brighton, Massachusetts, United States, 02135